


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
PCRX
Pacira BioSciences I
$24.77
Strengths

Earnings are forecast to grow
PCRX Price Performance
$23.86 (+3.81%)
$26.51 (-6.56%)
$22.17 (+11.73%)
$19.2 (+29.01%)
PCRX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

PCRX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Has a weak balance sheet

Below analyst estimate
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
PCRX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
PCRX Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is PCRX current stock price?
What are PCRX stock strengths?
What is PCRX Risk Level?
What is PCRX market cap and volume?
What is PCRX current Stock IQ?
Should I buy PCRX stock right now?
Is PCRX a Strong Buy right now?
What does a 'Strong Buy' rating mean for PCRX?
What does a 'Strong Sell' rating mean for PCRX?
What factors influence PCRX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
PCRX
Pacira BioSciences I
Current Price
$24.77
Stock Insights
Strengths

Earnings are forecast to grow

PCRX Price Performance
$23.86 (+3.81%)
$26.51 (-6.56%)
$22.17 (+11.73%)
$19.2 (+29.01%)
PCRX Analysts Opinion
PCRX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Has a weak balance sheet

Below analyst estimate
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
PCRX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
PCRX Street Sentiment is extremely bullish and have positive views on the near-term outlook
PCRX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
PCRX Stock IQ
PCRX Latest Analysis
ish Two Hundred Day Moving Average Cross - PCRX. In trading on Monday shares of Pacira BioSciences Inc (Symbol: PCRX) crossed above their 200 day moving average of $24.33 changing hands as high as $24.80 per share. Pacira BioSciences Inc shares are currently trading up about 1.8% on the day. The chart below shows the one y
Mon Dec 8, 2025
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical. -- Lawsuit triggers 30-month stay under the Hatch Waxman Act -- BRISBANE Calif. Nov. 26 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences Inc. (Nasdaq: PCRX) the industry leader in its commitment to deliver innovative non-opioid pain therapies to transform the lives of patients today announced that it has filed a patent infringement lawsuit in the United States District Court for the Dist
Wed Nov 26, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PCRX Stock trends
PCRX Stock performance
PCRX Stock analysis
PCRX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.